Moleculin Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Moleculin Biotech has a total shareholder equity of $17.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $25.6M and $7.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$10.85m |
| Equity | US$17.71m |
| Total liabilities | US$7.87m |
| Total assets | US$25.58m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0K2H's short term assets ($13.7M) exceed its short term liabilities ($5.7M).
Long Term Liabilities: 0K2H's short term assets ($13.7M) exceed its long term liabilities ($2.1M).
Debt to Equity History and Analysis
Debt Level: 0K2H is debt free.
Reducing Debt: 0K2H had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0K2H has sufficient cash runway for 5 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 0K2H is forecast to have sufficient cash runway for 5 months based on free cash flow estimates, but has since raised additional capital.